EICHORCondition: Obesity · Weight Loss · Metabolic Surgery · Sponsor: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
This clinical trial aims to evaluate the weight-loss efficacy and safety of efsubaglutide alfa in patients who remain obese 6 months after metabolic surgery.
This description comes directly from the study's public registry record.
wenhuan Feng · +86-25-83106666 · fengwh501@163.com
Always discuss trial participation with your own doctor first.
| Nanjing Drum Tower Hospital | Nanjing, Jiangsu, China | Recruiting |
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07163650